Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Current Pharmaceutical Analysis (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Current Pharmaceutical Analysis published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 91 of 371 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Current Pharmaceutical Analysis
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Current Pharmaceutical Analysis is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$2,100.
02Review time
Review time of Current Pharmaceutical Analysis
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Current Pharmaceutical Analysis published between Dec 2024 and Feb 2025 were accepted within 94 days of submission, and the middle half took between 60 and 116 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Pharmacology & Pharmacy, Current Pharmaceutical Analysis ranks 53 of 157 journals by review time (1 = fastest). See the fastest-review journals in Pharmacology & Pharmacy →
03Fee waivers
APC waivers and discounts for Current Pharmaceutical Analysis
Current Pharmaceutical Analysis follows the waiver policy of its publisher, Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Waivers apply to fully open access journals. If Current Pharmaceutical Analysis is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Current Pharmaceutical Analysis
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Current Pharmaceutical Analysis? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
04Indexing
Indexing of Current Pharmaceutical Analysis
- ISSN
- 1573-4129
- eISSN
- 1875-676X
- Publisher
- Bentham Science Publishers all its journals →
- Country
- U Arab Emirates
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Current Pharmaceutical Analysis
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Current Pharmaceutical Analysis accepts. You find it on the journal's website at Bentham Science Publishers, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Current Pharmaceutical Analysis is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Current Pharmaceutical Analysis
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Current Pharmaceutical Analysis, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
07Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Current Pharmaceutical Analysis when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 87 | Clinical Pharmacology & Therapeutics | 4.21 | SCIE | Subscription |
| 88 | International Journal for Parasitology Drugs and Drug Resistance | 4.21 | SCIE | Fully open access |
| 89 | Chinese Journal of Natural Medicines | 4.19 | SCIE | Subscription |
| 90 | Neuropharmacology | 4.16 | SCIE | Subscription |
| 92 | Journal of Microencapsulation | 4.09 | SCIE | Subscription |
| 93 | American Journal of Cardiovascular Drugs | 4.08 | SCIE | Subscription |
| 94 | Expert Review of Anti-infective Therapy | 4.08 | SCIE | Subscription |
| 95 | Current Opinion in Pharmacology | 4.05 | SCIE | Subscription |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
08Journal Finder
Find the right journal for your paper
Is Current Pharmaceutical Analysis right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Current Pharmaceutical Analysis?
Based on 52 research articles Current Pharmaceutical Analysis published from Dec 2024 to Feb 2025, the median time from submission to acceptance was 94 days, and half of them were accepted between 60 and 116 days. After acceptance, papers appeared online after a median of 121 days. Source: received and accepted dates deposited by the publisher in Crossref, retrieved October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Current Pharmaceutical Analysis?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Current Pharmaceutical Analysis is 4.14: papers it published in the two previous years were cited 4.14 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Current Pharmaceutical Analysis?
The h-index of Current Pharmaceutical Analysis is 35 (OpenAlex, October 2026): 35 of its papers have each been cited at least 35 times. Its i10-index is 243.
What is the APC of Current Pharmaceutical Analysis?
OpenAlex lists an article processing charge (APC) of about US$2,100 for Current Pharmaceutical Analysis (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Current Pharmaceutical Analysis?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Current Pharmaceutical Analysis is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Current Pharmaceutical Analysis indexed in Scopus?
Yes. Current Pharmaceutical Analysis appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Current Pharmaceutical Analysis an SCIE journal?
Yes. Current Pharmaceutical Analysis is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Current Pharmaceutical Analysis in Journal Citation Reports (JCR)?
Yes. Current Pharmaceutical Analysis is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Current Pharmaceutical Analysis offer an APC waiver?
Current Pharmaceutical Analysis follows the policy of Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Current Pharmaceutical Analysis?
27% of 188 recent research articles in Current Pharmaceutical Analysis name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, Guangxi Natural Science Foundation, Henan Provincial Science and Technology Research Project.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- International Journal of Molecular Sciences
- Value in Health
- Molecules
- Thin Solid Films
- Polymer
- Ceramics International
- Journal of Physical Chemistry B
- Environmental Science and Pollution Research
- Japanese Journal Of Applied Physics
- Applied Surface Science
- Journal of Magnetism and Magnetic Materials
- Astronomy and Astrophysics
- Journal of Cleaner Production
- International Journal of Hydrogen Energy
Browse all journals: indexing, impact factor and reviewer comments →